Global Remifentanil Hydrochloride 麻豆原创 Growth 2025-2031

Publication ID:

LPI07251120

Publication Date:

July 1, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Remifentanil Hydrochloride market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Remifentanil Hydrochloride (also named Ultiva) is a kind of white to off-white crystalline powder or crystals that used to maintain analgesia and anesthesia induction of general anesthesia. Remifentanil Hydrochloride is freely soluble in water, sparingly soluble in ethanol, slightly soluble in isopropyl alcohol and very slightly soluble in methyl isobutyl ketone.
Remifentanil Hydrochloride should be administered only in a setting fully equipped for the monitoring and support of respiratory and cardiovascular function and by persons specifically trained in the use of anaesthetic drugs and the recognition and management of the expected adverse effects of potent opioids, including respiratory and cardiac resuscitation. Such training must include the establishment and maintenance of a patent airway and assisted ventilation.
In Europe, Remifentanil Hydrochloride key players include GSK, Macfarlan Smith, Abbott, Mylan, Arevipharma, etc. The top five players hold a share about 85%.
UK is the largest market, with a share about 20%, followed by Germany and France, having a total share about 30 percent.
In terms of product, 1mg/Pcs is the largest segment, with a share about 85%. And in terms of application, the largest application is Endotracheal Intubation Operation, followed by Neurosurgery, Outpatient Surgery, Postoperative Analgesia, etc.
The 鈥淩emifentanil Hydrochloride Industry Forecast鈥� looks at past sales and reviews total world Remifentanil Hydrochloride sales in 2024, providing a comprehensive analysis by region and market sector of projected Remifentanil Hydrochloride sales for 2025 through 2031. With Remifentanil Hydrochloride sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Remifentanil Hydrochloride industry.
This Insight Report provides a comprehensive analysis of the global Remifentanil Hydrochloride landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Remifentanil Hydrochloride portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Remifentanil Hydrochloride market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Remifentanil Hydrochloride and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Remifentanil Hydrochloride.
This report presents a comprehensive overview, market shares, and growth opportunities of Remifentanil Hydrochloride market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
1mg/Pcs
2mg/Pcs
5mg/Pcs
Segmentation by Application:
Endotracheal Intubation Operation
Neurosurgery
Outpatient Surgery
Postoperative Analgesia
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GSK
Macfarlan Smith
Abbott
Mylan
Arevipharma
AMRI
Key Questions Addressed in this Report
What is the 10-year outlook for the global Remifentanil Hydrochloride market?
What factors are driving Remifentanil Hydrochloride market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Remifentanil Hydrochloride market opportunities vary by end market size?
How does Remifentanil Hydrochloride break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Remifentanil Hydrochloride Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Remifentanil Hydrochloride by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Remifentanil Hydrochloride by Country/Region, 2020, 2024 & 2031
2.2 Remifentanil Hydrochloride Segment by Type
2.2.1 1mg/Pcs
2.2.2 2mg/Pcs
2.2.3 5mg/Pcs
2.3 Remifentanil Hydrochloride Sales by Type
2.3.1 Global Remifentanil Hydrochloride Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Remifentanil Hydrochloride Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Remifentanil Hydrochloride Sale Price by Type (2020-2025)
2.4 Remifentanil Hydrochloride Segment by Application
2.4.1 Endotracheal Intubation Operation
2.4.2 Neurosurgery
2.4.3 Outpatient Surgery
2.4.4 Postoperative Analgesia
2.4.5 Other
2.5 Remifentanil Hydrochloride Sales by Application
2.5.1 Global Remifentanil Hydrochloride Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Remifentanil Hydrochloride Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Remifentanil Hydrochloride Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Remifentanil Hydrochloride Breakdown Data by Company
3.1.1 Global Remifentanil Hydrochloride Annual Sales by Company (2020-2025)
3.1.2 Global Remifentanil Hydrochloride Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Remifentanil Hydrochloride Annual Revenue by Company (2020-2025)
3.2.1 Global Remifentanil Hydrochloride Revenue by Company (2020-2025)
3.2.2 Global Remifentanil Hydrochloride Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Remifentanil Hydrochloride Sale Price by Company
3.4 Key Manufacturers Remifentanil Hydrochloride Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Remifentanil Hydrochloride Product Location Distribution
3.4.2 Players Remifentanil Hydrochloride Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Remifentanil Hydrochloride by Geographic Region
4.1 World Historic Remifentanil Hydrochloride 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Remifentanil Hydrochloride Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Remifentanil Hydrochloride Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Remifentanil Hydrochloride 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Remifentanil Hydrochloride Annual Sales by Country/Region (2020-2025)
4.2.2 Global Remifentanil Hydrochloride Annual Revenue by Country/Region (2020-2025)
4.3 Americas Remifentanil Hydrochloride Sales Growth
4.4 APAC Remifentanil Hydrochloride Sales Growth
4.5 Europe Remifentanil Hydrochloride Sales Growth
4.6 Middle East & Africa Remifentanil Hydrochloride Sales Growth
5 Americas
5.1 Americas Remifentanil Hydrochloride Sales by Country
5.1.1 Americas Remifentanil Hydrochloride Sales by Country (2020-2025)
5.1.2 Americas Remifentanil Hydrochloride Revenue by Country (2020-2025)
5.2 Americas Remifentanil Hydrochloride Sales by Type (2020-2025)
5.3 Americas Remifentanil Hydrochloride Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Remifentanil Hydrochloride Sales by Region
6.1.1 APAC Remifentanil Hydrochloride Sales by Region (2020-2025)
6.1.2 APAC Remifentanil Hydrochloride Revenue by Region (2020-2025)
6.2 APAC Remifentanil Hydrochloride Sales by Type (2020-2025)
6.3 APAC Remifentanil Hydrochloride Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Remifentanil Hydrochloride by Country
7.1.1 Europe Remifentanil Hydrochloride Sales by Country (2020-2025)
7.1.2 Europe Remifentanil Hydrochloride Revenue by Country (2020-2025)
7.2 Europe Remifentanil Hydrochloride Sales by Type (2020-2025)
7.3 Europe Remifentanil Hydrochloride Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Remifentanil Hydrochloride by Country
8.1.1 Middle East & Africa Remifentanil Hydrochloride Sales by Country (2020-2025)
8.1.2 Middle East & Africa Remifentanil Hydrochloride Revenue by Country (2020-2025)
8.2 Middle East & Africa Remifentanil Hydrochloride Sales by Type (2020-2025)
8.3 Middle East & Africa Remifentanil Hydrochloride Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Remifentanil Hydrochloride
10.3 Manufacturing Process Analysis of Remifentanil Hydrochloride
10.4 Industry Chain Structure of Remifentanil Hydrochloride
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Remifentanil Hydrochloride Distributors
11.3 Remifentanil Hydrochloride Customer
12 World Forecast Review for Remifentanil Hydrochloride by Geographic Region
12.1 Global Remifentanil Hydrochloride 麻豆原创 Size Forecast by Region
12.1.1 Global Remifentanil Hydrochloride Forecast by Region (2026-2031)
12.1.2 Global Remifentanil Hydrochloride Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Remifentanil Hydrochloride Forecast by Type (2026-2031)
12.7 Global Remifentanil Hydrochloride Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Remifentanil Hydrochloride Product Portfolios and Specifications
13.1.3 GSK Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Macfarlan Smith
13.2.1 Macfarlan Smith Company Information
13.2.2 Macfarlan Smith Remifentanil Hydrochloride Product Portfolios and Specifications
13.2.3 Macfarlan Smith Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Macfarlan Smith Main Business Overview
13.2.5 Macfarlan Smith Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Remifentanil Hydrochloride Product Portfolios and Specifications
13.3.3 Abbott Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Mylan
13.4.1 Mylan Company Information
13.4.2 Mylan Remifentanil Hydrochloride Product Portfolios and Specifications
13.4.3 Mylan Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Mylan Main Business Overview
13.4.5 Mylan Latest Developments
13.5 Arevipharma
13.5.1 Arevipharma Company Information
13.5.2 Arevipharma Remifentanil Hydrochloride Product Portfolios and Specifications
13.5.3 Arevipharma Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Arevipharma Main Business Overview
13.5.5 Arevipharma Latest Developments
13.6 AMRI
13.6.1 AMRI Company Information
13.6.2 AMRI Remifentanil Hydrochloride Product Portfolios and Specifications
13.6.3 AMRI Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 AMRI Main Business Overview
13.6.5 AMRI Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.